Literature DB >> 8583615

Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors.

I Leibovitch1, J S Little, R S Foster, R G Rowland, R Bihrle, J P Donohue.   

Abstract

PURPOSE: We reviewed current experience at our university with delayed orchiectomy after chemotherapy in patients with metastatic nonseminomatous germ cell tumors.
MATERIALS AND METHODS: We retrospectively analyzed the records of 160 patients with metastatic germ cell cancer who were given systemic chemotherapy, and subsequently underwent orchiectomy and retroperitoneal lymph node dissection.
RESULTS: Analysis of 160 testicular specimens revealed necrosis or scar in 70 (43.7%), pure teratoma in 50 (31.2%) and persistent germ cell cancer in 40 (25%). Corresponding incidences of histopathological findings in the post-chemotherapy retroperitoneal lymph node dissection specimens were significantly different, correlating with less than half of the cases (chi-square, p = 0.002).
CONCLUSIONS: Our study confirms the need for delayed orchiectomy after systemic chemotherapy even when there seems to be a partial or complete clinical response at other sites.

Entities:  

Mesh:

Year:  1996        PMID: 8583615

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  [Organ-sparing surgery for testicular tumors].

Authors:  L Weissbach; C Schaefer
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

2.  Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.

Authors:  D Ondrus; M Hornák; J Breza; J Mat'oska; M Schnorrer; V Belan; J Kausitz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.

Authors:  Robert J Hamilton; Christina Canil; Noa Shani Shrem; Kopika Kuhathaas; Maria Di Jiang; Peter Chung; Scott North; Piotr Czaykowski; Sebastien Hotte; Eric Winquist; Christian Kollmannsberger; Armen Aprikian; Denis Soulières; Scott Tyldesley; Alan I So; Nicholas Power; Ricardo A Rendon; Martin O'Malley; Lori Wood; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

4.  Is the testis a chemo-privileged site? Is there a blood-testis barrier?

Authors:  Dhiren S Dave; John T Leppert; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

5.  Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report.

Authors:  Angela Mweempwa; Alvin Tan; Michael Dray
Journal:  J Med Case Rep       Date:  2016-11-05

Review 6.  Role of chemotherapy prior to orchiectomy in metastatic testicular cancer-is testis really a sanctuary site?

Authors:  B Vinusha Reddy; A Sivakanth; G Naveen Babu; Krishnamurthy Swamyvelu; Yg Basavana Goud; Ba Madhusudhana; Vasu Reddy Challa
Journal:  Ecancermedicalscience       Date:  2014-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.